Induction of Type 1 Immune Responses to SIV by IFN-Gamma
Abstract
Our long term goal is the development of a safe and efficacious vaccine against infection with the human immunodeficiency virus (HIV). The immediate objective of this study is to develop vaccinia virus (VV) vector vaccines against acquired immunodeficiency syndrome (AIDS) using simian immunodeficiency virus (SIV) as a model in rhesus macaques.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 1997
- Accession Number
- ADB227112
Entities
People
- Tilahun D. Yilma
Organizations
- University of California